Stay updated on PK and Safety of Omalizumab in Healthy Subjects Clinical Trial
Sign up to get notified when there's something new on the PK and Safety of Omalizumab in Healthy Subjects Clinical Trial page.

Latest updates to the PK and Safety of Omalizumab in Healthy Subjects Clinical Trial page
- Check4 days agoChange DetectedA notice about NIH’s terminology transition was added, linking to updates and FAQs and stating that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check11 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check18 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check39 days agoChange DetectedRevision: v3.7.0 is now shown, and a large set of study documents and related items in the Study Documents section were removed. The update changes what materials are readily available for review and verification of the study record.SummaryDifference18%

- Check60 days agoChange DetectedThe page revision tag was updated from v3.6.5 to v3.6.6, indicating a minor internal update to the page framework. The user-facing content and study details appear unchanged.SummaryDifference0.1%

- Check81 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a new deployment of the page. This update reflects an internal change to the page rather than a modification to the study details or user-facing content.SummaryDifference0.1%

Stay in the know with updates to PK and Safety of Omalizumab in Healthy Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PK and Safety of Omalizumab in Healthy Subjects Clinical Trial page.